Quick Answer
NEPHROS INC reported Total Revenue of $18.79 million for fiscal year 2025.
NEPHROS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $18.79M +32.7% |
$14.16M -0.5% |
$14.24M +42.7% |
$9.97M -2.4% |
$10.22M +19.3% |
$8.56M -17.2% |
| Revenue (ASC 606) | $18.79M +32.7% |
$14.16M -0.5% |
$14.24M +42.7% |
$9.97M -2.4% |
$10.22M +19.3% |
$8.56M -17.2% |
| Net Income | $1.19M +1513.5% |
$74.0K +104.7% |
-$1.57M | — | -$3.87M +14.6% |
-$4.53M -42.4% |
| Diluted EPS | $0.11 +1000.0% |
$0.01 +106.7% |
-$0.15 +79.5% |
-$0.73 | — | — |
| Total Assets | $13.64M +21.7% |
$11.21M -5.5% |
$11.86M +7.8% |
$11.00M -37.7% |
$17.65M -4.6% |
$18.51M +59.2% |
| Cash and Equivalents | $5.40M +43.6% |
$3.76M -12.7% |
$4.31M +18.5% |
$3.63M -47.9% |
$6.97M -15.5% |
$8.25M +98.0% |
| Stockholders Equity | $10.20M +18.8% |
$8.59M +2.7% |
$8.36M +49.5% |
$5.59M -52.2% |
$11.70M -6.6% |
$12.52M +167.9% |
| R&D Expense | $1.34M +47.8% |
$906.0K +3.8% |
$873.0K -30.4% |
$1.25M -16.2% |
$1.50M -45.7% |
$2.76M -10.7% |
| Operating Income | $1.15M +19000.0% |
$6.0K +100.4% |
-$1.59M +63.3% |
-$4.33M -33.3% |
-$3.25M +23.9% |
-$4.28M -35.5% |
| Gross Profit | $11.62M +33.3% |
$8.72M +3.8% |
$8.40M +77.7% |
$4.73M -16.0% |
$5.63M +14.7% |
$4.91M -19.2% |
| Shares Outstanding | 10.64M +0.9% |
10.54M +0.0% |
10.54M +2.4% |
10.30M +0.4% |
10.26M +3.9% |
9.87M -85.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $4.76M | +35.4% | +7.8% |
| Revenue (ASC 606) | September 30, 2025 | $4.76M | +35.4% | +7.8% |
| Net Income | September 30, 2025 | $337.0K | +84.2% | +42.2% |
| Diluted EPS | September 30, 2025 | $0.03 | +50.0% | +50.0% |
| Total Assets | September 30, 2025 | $13.25M | +27.5% | +8.2% |
| Cash and Equivalents | September 30, 2025 | $5.17M | +110.5% | +1.9% |
| Stockholders Equity | September 30, 2025 | $10.01M | +22.4% | +4.2% |
| R&D Expense | September 30, 2025 | $338.0K | +79.8% | +8.7% |
| Operating Income | September 30, 2025 | $314.0K | +52.4% | +26.6% |
| Gross Profit | September 30, 2025 | $2.92M | +35.6% | +4.3% |
| Shares Outstanding | September 30, 2025 | 10.63M | +0.8% | +0.2% |
- NEPHROS INC reported Total Revenue of $18.79 million for fiscal year 2025.
- NEPHROS INC showed an increase of +32.7% in Total Revenue compared to the prior fiscal year.
- NEPHROS INC reported Revenue (ASC 606) of $18.79 million for fiscal year 2025.
- NEPHROS INC showed an increase of +32.7% in Revenue (ASC 606) compared to the prior fiscal year.
- NEPHROS INC reported Net Income of $1.19 million for fiscal year 2025.
- NEPHROS INC showed an increase of +1513.5% in Net Income compared to the prior fiscal year.
- NEPHROS INC reported Diluted EPS of $0.11 per share for fiscal year 2025.
- NEPHROS INC showed an increase of +1000.0% in Diluted EPS compared to the prior fiscal year.
- NEPHROS INC reported Total Assets of $13.64 million for fiscal year 2025.
- NEPHROS INC showed an increase of +21.7% in Total Assets compared to the prior fiscal year.
- NEPHROS INC reported Cash and Equivalents of $5.40 million for fiscal year 2025.
- NEPHROS INC showed an increase of +43.6% in Cash and Equivalents compared to the prior fiscal year.
- NEPHROS INC reported Stockholders Equity of $10.20 million for fiscal year 2025.
- NEPHROS INC showed an increase of +18.8% in Stockholders Equity compared to the prior fiscal year.
- NEPHROS INC reported R&D Expense of $1.34 million for fiscal year 2025.
- NEPHROS INC showed an increase of +47.8% in R&D Expense compared to the prior fiscal year.
- NEPHROS INC reported Operating Income of $1.15 million for fiscal year 2025.
- NEPHROS INC showed an increase of +19000.0% in Operating Income compared to the prior fiscal year.
- NEPHROS INC reported Gross Profit of $11.62 million for fiscal year 2025.
- NEPHROS INC showed an increase of +33.3% in Gross Profit compared to the prior fiscal year.
- NEPHROS INC reported Shares Outstanding of 10.64 million shares for fiscal year 2025.
- NEPHROS INC showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: